Three quick notes:
1. The April 30 recall applies to polyethylene implants manufactured between December 2016 and January 2017, and distributed between December 2016 and February 2020.
2. During a routine bacterial endotoxin testing of polyethylene implants, three samples were found to exceed accepted standards for endotoxin levels during a six-week period.
3. Zimmer Biomet did not receive any complaints related to the issue, which could cause adverse local tissue reactions, critical pain or aches, and severe, systemic reactions.
More articles on devices:
Dr. Khawar Siddique: California 2nd elective surgery shutdown ‘only a matter of time’
Johnson & Johnson’s Q2 knee sales tumble 50% in the US — 6 earnings insights
12 insights on orthopedic surgeon net worth, debt & compensation
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.